INVESTIGATION OF BMI, ETC CHANGES FOLLOWING A SWITCH FROM OLANZAPINE

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 通过这项研究，我们希望找出阿立哌唑是否可以逆转人们在服用奥氮平、瑞培酮或奎硫平时出现的体重增加和高血糖、血脂或血压问题。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. With this study, we hope to find out if aripiprazole can reverse weight gain and problems with high blood sugar, lipids or blood pressure that have developed while people have been taking olanzapine, resperidone or quetiapine.